Mastering Competitiveness in Pharma | By Trilations
Mastering Competitiveness in Pharma | By Trilations
Podcast Description
In today’s rapidly shifting pharmaceutical landscape, competitiveness is more than just market share—it’s about differentiation, value creation, and strategic alignment between commercial and medical functions. In this podcast series, we bring together top executives to share how they benchmark success, optimize collaboration, and drive impact in a competitive market.
Podcast Insights
Content Themes
The podcast explores critical themes in the pharmaceutical industry including the evolving role of medical affairs, competitiveness, and value creation, with episode examples such as strategies for benchmarking success and enhancing patient-centricity in pharma. Focus areas also include the integration of medical and commercial functions to drive impact.
In today’s rapidly shifting pharmaceutical landscape, competitiveness is more than just market share—it’s about differentiation, value creation, and strategic alignment between commercial and medical functions. In this podcast series, we bring together top executives to share how they benchmark success, optimize collaboration, and drive impact in a competitive market.
Annie Curti, Director and Launch Excellence Lead at Novartis, brings over 15 years of experience in life sciences consulting and biopharma leadership. In this episode of Mastering Competitiveness, she shares what it takes to launch successfully in today’s complex pharma environment: from aligning cross-functional teams to defining the right success metrics and keeping patient needs at the center.
We discuss how launch teams can stay agile, balance global and local dynamics, and go beyond clinical differentiation to compete effectively from day one.
In this episode, we explore:
(03:37) How the healthcare stakeholder landscape is evolving
(08:08) Overcoming cross-functional collaboration challenges
(10:38) Reinventing the company with customer focus
(13:19) Enhancing patient-centric communication
(18:02) Exploring non-clinical competitive advantages
(20:20) Data-driven strategy and execution
(21:07) Competitiveness in pharma over the next 10 to 15 years
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.